Your industry news - first Number 1 for Recruitment
We strongly recommend viewing Cleanzine full size in your web browser. Click our masthead above to visit our website version.
AirPHX technology confirmed in reducing HAI and GCBR
Effective on both airborne and surface pathogens, airPHX technology provides continuous infection control for the healthcare industry and is said to offer a cost-effective alternative to existing infection control protocols. Using a proprietary application of atmospheric cold plasma, airPHX is both scalable and affordable, and has been proven effective on 30 common HAI pathogens including bacteria, viruses and protozoa.
The manufacturer has confirmed successful results from deployment of its patented non-thermal plasma technology in two live hospital environments.
The first, in a Mid-Atlantic US hospital, involves treating an entire oncology wing and the emergency room with just one airPHX device each. Results include consistent 91-99% reductions in surface and airborne pathogens throughout the entire treatment space, including high-touch surfaces, with benefits extending into adjacent floors.
Along with Healthcare Acquired Infections, naturally occurring microorganisms that constitute a Global Catastrophic Biological Risk are becoming a topic of increasingly urgent concern. Severe infectious diseases, e.g. severe acute respiratory syndrome (SARs), adenovirus and Ebola, present pandemic potential with solutions limited by geography and financial resources.
As well as healthcare facilities, AirPHX technology can be deployed in remote clinics, transportation or any environment that exposes patients, aid workers and staff to infection risk. Disbursing a low level of reactive oxygen species (ROS), it works continuously in the background as a prophylaxis with no labor costs and minimal operating expenses. The ROS operate as an oxidiser of pathogens, eliminating pathogens in the air and on all surfaces exposed to ambient air. AirPHX technology destroys pathogens on over 30 viruses, bacteria and protozoa with over four log reductions in organisms in a 30-minute period. airPHX is currently deployed in over 50 facilities with uniformly consistent results.
17th January 2019